[1]
|
Ponikowski, P., Voors, A.A., Anker, S.D., Bueno, H., Cleland, J.G.F., Coats, A.J.S., et al. (2016) 2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure. European Heart Journal, 37, 2129-2200.
https://doi.org/10.1093/eurheartj/ehw128
|
[2]
|
Butler, J., Fonarow, G.C., Zile, M.R., Lam, C.S., Roessig, L., Schelbert, E.B., Shah, S.J., Ahmed, A., Bonow, R.O., Cleland, J.G.F., Cody, R.J., Chioncel, O., Collins, S.P., Dunnmon, P., Filippatos, G., Lefkowitz, M.P., Marti, C.N., McMurray, J.J., Misselwitz, F., Nodari, S., O’Connor, C., Pfeffer, M.A., Pieske, B., Pitt, B., Rosano, G., Sabbah, H.N., Senni, M., Solomon, S.D., Stockbridge, N., Teerlink, J.R., Georgiopoulou, V.V. and Gheorghiade, M. (2014) Developing Therapies for Heart Failure with Preserved Ejection Fraction: Current State and Future Directions. JACC Heart Fail, 2, 97-112. https://doi.org/10.1016/j.jchf.2013.10.006
|
[3]
|
McMurray, J.J.V. (2010) Clinical Practice. Systolic Heart Failure. New England Journal of Medicine, 3623, 228-238.
|
[4]
|
Dunlay, S.M., Redfield, M.M., Weston, S.A., Therneau, T.M., Hall Long, K., Shah, N.D. and Roger, V.L. (2009) Hospitalizations after Heart Failure Diagnosis A Community Perspective. Journal of the American College of Cardiology, 54, 1695-1702.
https://doi.org/10.1016/j.jacc.2009.08.019
|
[5]
|
McDonagh, T.A., Dargie, H.J., Szwejkowski, B.R., Rekhraj, S., Struthers, A., Adamopoulos, S., Georgiadou, P. and Voudris, V. (2011) Pathophysiology of Heart Failure. In: Oxford Textbook of Heart Failure, Oxford University Press, Oxford, 131. https://doi.org/10.1093/med/9780199577729.003.0013
|
[6]
|
Solomon, S.D., Dobson, J., Pocock, S., Skali, H., McMurray, J.J., Granger, C.B., Yusuf, S., Swedberg, K., Young, J.B., Michelson, E.L. and Pfeffer, M.A. (2007) Influence of Nonfatal Hospitalization for Heart Failure on Subsequent Mortality in Patients with Chronic Heart Failure. Circulation, 116, 1482-1487.
https://doi.org/10.1161/CIRCULATIONAHA.107.696906
|
[7]
|
Antzelevitch, C., Brugada, P., Borggrefe, M., Brugada, J., Brugada, R., Corrado, D., Gussak, I., LeMarec, H., Nademanee, K., Perez Riera, A.R. and Shimizu, W. (2005) Brugada Syndrome: Report of the Second Consensus Conference: Endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation, 111, 659-670. https://doi.org/10.1161/01.CIR.0000152479.54298.51
|
[8]
|
Entresto, F.L. (2015) (Sacubitril/Valsartan): First-in-Class Angiotensin Receptor Neprilysin Inhibitor FDA Approved for Patients with Heart Failure. American Health & Drug Benefits, 8, 330.
|
[9]
|
Vos, T., Allen, C., Arora, M., Barber, R.M., Bhutta, Z.A., Brown, A., Carter, A., Casey, D.C., Charlson, F.J., Chen, A.Z. and Coggeshall, M. (2016) Global, Regional, and National Incidence, Prevalence, and Years Lived with Disability for 310 Diseases and Injuries, 1990-2015: A Systematic Analysis for the Global Burden of Disease Study 2015. The Lancet, 388, 1545-1602.
|
[10]
|
Metra, M. and Teerlink, J.R. (2017) Heart Failure. The Lancet, 390, 1981-1995.
https://doi.org/10.1016/S0140-6736(17)31071-1
|
[11]
|
Dickstein, K., Cohen-Solal, A., Filippatos, G., McMurray, J.J., Ponikowski, P., Poole-Wilson, P.A., Stromberg, A., van Veldhuisen, D.J., Atar, D. and Hoes, A.W. (2008) ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in Collaboration with the Heart Failure Association of the ESC (HFA) and Endorsed by the European Society of Intensive Care Medicine (ESICM). European Journal of Heart Failure, 10, 933-989.
|
[12]
|
Boulpaep, E.L., Boron, W.F., Caplan, M.J., Cantley, L., Igarashi, P., Aronson, P.S. and Moczydlowski, E. (2009) Medical Physiology a Cellular and Molecular Approach. Signal Transduction, 48, 27.
|
[13]
|
Yancy, C.W., Jessup, M., Bozkurt, B., Butler, J., Casey, D.E., Colvin, M.M., Drazner, M.H., Filippatos, G.S., Fonarow, G.C., Givertz, M.M. and Hollenberg, S.M. (2017) ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Journal of the American College of Cardiology, 70, 776-803. https://doi.org/10.1161/CIR.0000000000000509
|
[14]
|
Sahn, D.J., DeMaria, A., Kisslo, J. and Weyman, A. (1978) Recommendations Regarding Quantification in M-Mode Echocardiography: Results of a Survey of Echocardiographic Measurements. Circulation, 58, 1072-1083.
https://doi.org/10.1161/01.CIR.58.6.1072
|
[15]
|
Lester, S.J., Ryan, E.W., Schiller, N.B. and Foster, E. (1999) Best Method in Clinical Practice and Research Studies to Determine Left Atrial Size. American Journal of Cardiology, 84, 829-832. https://doi.org/10.1016/S0002-9149(99)00446-4
|
[16]
|
Schiller, N., Shah, P.M., Crawford, M., DeMaria, A., Devereux, R., Feigenbaum, H., et al. (1989) Recommendations for Quantification of the Left Ventricle by Two-Dimensional Echocardiography: American Society of Echocardiography Subcommittee on Standards. Journal of the American Society of Echocardiography, 2, 358-368. https://doi.org/10.1016/S0894-7317(89)80014-8
|
[17]
|
Nagueh, S., Appleton, C.P., Gillebert, T.C., Marino, P.N., Oh, J.K., Smisteh, O.A., et al. (2009) Recommandations of the Evaluation of Diastolic Dysfunctions by Echocardiography. Journal of the American Society of Echocardiography, 22, 108-128.
https://doi.org/10.1016/j.echo.2008.11.023
|
[18]
|
Hollekim-Strand, S.M., Hoydahl, S.F., Follestad, T., Dalen, H., Bjorgaas, M.R., Wisloff, U., et al. (2016) Exercise Training Normalizes Timing of Left Ventricular Untwistrate, But Not Peak Untwist Rate, in Individuals with Type 2 Diabetes and Diastolic Dysfunction: A Pilot Study. Journal of the American Society of Echocardiography, 29, 421-430. https://doi.org/10.1016/j.echo.2016.01.005
|
[19]
|
Januzzi, J.L., Prescott, M.F., Butler, J., Felker, G.M., Maisel, A.S., McCague, K., Camacho, A., Pina, I.L., Rocha, R.A., Shah, A.M. and Williamson, K.M. (2019) Association of Change in N-Terminal Pro-B-Type Natriuretic Peptide Following Initiation of Sacubitril-Valsartan Treatment with Cardiac Structure and Function in Patients with Heart Failure with Reduced Ejection Fraction. JAMA, 322, 1085-1095.
https://doi.org/10.1001/jama.2019.12821
|
[20]
|
D’Elia, E., Iacovoni, A., Vaduganathan, M., Lorini, F.L., Perlini, S. and Senni, M. (2017) Neprilysin Inhibition in Heart Failure: Mechanisms and Substrates beyond Modulating Natriuretic Peptides. European Journal of Heart Failure, 19, 710-717.
https://doi.org/10.1002/ejhf.799
|
[21]
|
Bayes-Genis, A., Barallat, J. and Richards, A.M. (2016) A Test in Context: Neprilysin: Function, Inhibition, and Biomarker. Journal of the American College of Cardiology, 68, 639-653. https://doi.org/10.1016/j.jacc.2016.04.060
|
[22]
|
Wang, Y., Zhou, R., Lu, C., Chen, Q., Xu, T. and Li, D. (2019) Effects of the Angiotensin-Receptor Neprilysin Inhibitor on Cardiac Reverse Remodeling: Meta-Analysis. Journal of the American Heart Association, 8, e012272.
https://doi.org/10.1161/JAHA.119.012272
|
[23]
|
Januzzi, J.L., et al. (2019) Association of Change in N-Terminal Pro-B-Type Natriuretic Peptide Following Initiation of Sacubitril-Valsartan Treatment with Cardiac Structure and Function in Patients with Heart Failure with Reduced Ejection Fraction. JAMA, 322, 1085-1095.
|
[24]
|
Romano, G., et al. (2019) The Effects of Sacubitril/Valsartan on Clinical, Bioumoral and Echocardiographic Parameters in Patients with Heart Failure with Reduced Ejection Fraction: The “Hemodynamic Reverse Remodeling”.
https://doi.org/10.3390/jcm8122165
|
[25]
|
Vitale, G., Romano, G., Di Franco, A., Caccamo, G., Nugara, C., Ajello, L., Storniolo, S., Sarullo, S., Agnese, V., Giallauria, F. and Novo, G. (2019) Early Effects of Sacubitril/Valsartan on Exercise Tolerance in Patients with Heart Failure with Reduced Ejection Fraction. Journal of Clinical Medicine, 8, 262.
https://doi.org/10.3390/jcm8020262
|
[26]
|
Buchalter, M.B., Rademakers, F.E., Weiss, J.L., Rogers, W.J., Weisfeldt, M.L. and Shapiro, E.P. (1994) Rotational Deformation of the Canine Left Ventricle Measured by Magnetic Resonance Tagging: Effects of Catecholamines, Ischaemia, and Pacing. Cardiovascular Research, 28, 629-635. https://doi.org/10.1093/cvr/28.5.629
|
[27]
|
Yun, K.L., Niczyporuk, M.A., Daughters, G.T., Ingels, N.B., Stinson, E.B., Alderman, E.L., Hansen, D.E. and Miller, D.C. (1991) Alterations in Left Ventricular Diastolic Twist Mechanics during Acute Human Cardiac Allograft Rejection. Circulation, 83, 962-973. https://doi.org/10.1161/01.CIR.83.3.962
|
[28]
|
Rademakers, F.E., Buchalter, M.B., Rogers, W.J., Zerhouni, E.A., Weisfeldt, M.L., Weiss, J.L. and Shapiro, E.P. (1992) Dissociation between Left Ventricular Untwisting and Filling. Accentuation by Catecholamines. Circulation, 85, 1572-1581.
https://doi.org/10.1161/01.CIR.85.4.1572
|
[29]
|
Dong, S., Hees, P., Siu, C., Weiss, J. and Shapiro, E. (2001) MRI Assessment of LV Relaxation by Untwisting Rate: A New Isovolumic Phase Measure of Tau. The American Journal of Physiology—Heart and Circulatory Physiology, 281, H2002-H2009.
https://doi.org/10.1152/ajpheart.2001.281.5.H2002
|